Trials / Completed
CompletedNCT04978740
Ocular and Palpebral Manifestations of Mastocytosis (MOOMA)
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 21 (actual)
- Sponsor
- Poitiers University Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Mastocytosis is a rare condition characterized by an accumulation of mast cell cells in one or more organs such as the liver, bone marrow, spleen and intestines. Its prevalence in the general population is 1 in 10,000. This pathology is due to the proliferation of a mast cell clone and the excessive release of inflammatory mediators which lead to abnormal tissue infiltration. To date, there are only a few cases reporting ocular and orbital manifestations of mastocytosis. Our prospective, interventional and single-center study consist in describing the ocular functional manifestations and ocular surface abnormalities of patients with systemic and cutaneous mastocytosis.
Detailed description
Patient with systemic or cutaneous mastocytosis will be included in the study. Data about organ involvement of mastocytosis will be collected. Participants will be screened with a medical and eye disease history. They will also have an eye exam. Participants will provide a tears sample.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Ophthalmological examination | Eye examination : Ocular tonometry to determine intraocular pressure Refraction assessment Retina examination Slit lamp examination Visual acuity Schirmer's test Corneal topography Funduscopic examination Optical coherence tomography |
Timeline
- Start date
- 2021-07-30
- Primary completion
- 2021-09-03
- Completion
- 2021-09-03
- First posted
- 2021-07-27
- Last updated
- 2022-12-01
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT04978740. Inclusion in this directory is not an endorsement.